Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of May 2025. The report specifically details a transaction in the company's own shares executed under a share buyback programme announced on March 28, 2025.
Key Financial Metrics
The filing does not provide comprehensive financial statements such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to the share repurchase activity on May 6, 2025:
- Shares Purchased: 832,200 ordinary shares
- Highest Price Paid: 402.60 pence per share
- Lowest Price Paid: 396.80 pence per share
- Volume Weighted Average Price: 398.73 pence per share
- Post-Transaction Share Capital: 9,019,214,172 ordinary shares
- Treasury Shares Held: 4,080,205
- Voting Shares Outstanding: 9,015,133,967
Material Changes
The primary material change reported is the reduction in the number of outstanding shares due to the cancellation of 832,200 shares purchased on May 6, 2025. This action reduces the total share count and adjusts the number of shares with voting rights.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future performance, or discussion of risks and contingencies. It is a routine disclosure of a completed share transaction. The text includes a standard disclaimer that the announcement does not constitute an offer or solicitation of an offer for securities.
Investor Verification Checklist
- Verify the total number of shares purchased under the buyback programme since its inception on March 28, 2025.
- Confirm the remaining authorization limit for the current buyback programme.
- Review the full trade breakdown available via the provided London Stock Exchange link for granular transaction details.
- Check subsequent filings for updates on the company's broader financial performance, as this 6-K does not contain earnings data.